Correo Electrónico
DNINFOA - SIA
Bibliotecas
Convocatorias
Identidad U.N.
Publicado
Pancreatic cancer incidence and mortality trends: a population-based study
Incidencia de cáncer pancreático y tendencias de mortalidad: un estudio basado en la población
DOI:
https://doi.org/10.15446/rsap.v24n1.89397Palabras clave:
Neoplasms, pancreatic neoplasms, mortality, incidence, Latin America, epidemiology (en)Neoplasias, neoplasias pancreáticas, mortalidad, incidencia, America Latina, epidemiología (es)
Descargas
Objectives To analyze trends in pancreatic cancer incidence and mortality in Latin American countries.
Methods An ecological study with incidence data from the International Agency for Research on Cancer and mortality data from the World Health Organization. The trend of incidence by Joinpoint regression, the variation of the annual average and the 95% confidence interval were analyzed.
Results There were increasing trends in incidence in Brazil, in males, aged 40-59 years, and reduction in Costa Rica. In females, there was stability in all age groups. The mortality rates increased in the elderly in Brazil (AAPC: 1.09%; 95% CI: 0.76; 1.42), Peru (AAPC: 1.76%; 95% CI: 0.36; 3.17) and El Salvador (AAPC: 2.88%; 95% CI: 0.38; 5.43), while in Mexico, there was a reduction. In females, this rate increased in Brazil (AAPC: 1.38%; 95% CI: 1.07; 1.69), Peru (AAPC: 2.25%; 95% CI: 0.68; 3.85), Chile (AAPC: 3.62%; 95% CI:1.96; 5.31), Nicaragua (AAPC: 2.51%; 95% CI: 0.36; 4.71) and Paraguay (AAPC: 1.17%; 95% CI: 0.37; 1.98) and a downward trend was observed in Colombia and Ecuador.
Conclusions Pancreatic cancer had a higher incidence in the elderly population of both sexes and an increase of the mortality trend in females was noted.
Objetivo Analizar las tendencias en la incidencia y mortalidad por cáncer de páncreas en los países latinoamericanos.
Método Se realizó un estudio ecológico con datos de incidencia de la Agencia Internacional de Investigación sobre Cáncer y datos de mortalidad de la Organización Mundial de la Salud. Se analizó la tendencia de incidencia por regresión de Joinpoint, la variación del promedio anual y el intervalo de confianza del 95%.
Resultados Hubo tendencias crecientes en la incidencia en Brasil en varones entre 40 y 59 años, y una reducción en Costa Rica. En las mujeres, hubo estabilidad en todos los grupos de edad. Las tasas de mortalidad aumentaron en los ancianos en Brasil (AAPC: 1,09%; IC95%: 0,76; 1.42), Perú (AAPC: 1,76%; IC 95%: 0,36; 3,17) y El Salvador (AAPC: 2,88%; 95% IC 0,38; 5,43), mientras que en México hubo una reducción. En las mujeres, esta tasa aumentó en Brasil (AAPC: 1,38%; IC 95%: 1,07; 1.69), Perú (AAPC: 2,25%; IC 95%: 0,68; 3.85), Chile (AAPC: 3,62%; IC 95%: 1,96; 5,31), Nicaragua (AAPC: 2,51%; IC 95%: 0,36; 4,71) y Paraguay (AAPC: 1,17%; IC 95%: 0,37; 1,98) y se observó una tendencia a la baja en Colombia y Ecuador.
Conclusiones El cáncer de páncreas tuvo una mayor incidencia en la población anciana de ambos sexos; cabe también señalar que debido a este aumentó su mortalidad en las mujeres.
Referencias
Caglevic C, de la Torre M, Mahave M, Müller B, Solé S, Moscoso Y, et al. Recomendaciones sobre el manejo del cáncer de páncreas tipo adenocarcinoma en Latinoamérica: Reunión del Consenso del Simpo-sio Latinoamericano de Gastroenterología Oncológica (SLAGO) y de la Asociación Ibero Latinoamericana de Terapia Radiante (ALATRO). Rev. Méd. Chile. 2016; 144(1):1305-18. http://dx.doi.org/10.4067/S0034-98872016001000010.
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J. Clin. 2018; 68(6):394-424. https://doi.org/10.3322/caac.21492.
Sierra MS, Soerjomataram I, Antoni S, Laversanne M, Piñeros M, de Vries E, et al. Cancer patterns and trends in Central and South America. Cancer Epidemiology. 2016; 44:23-42. https://doi.org/10.1016/j.canep.2016.07.013.
Barbosa IR, de Souza DL, Bernal MM, do CC Costa Í. Cancer mortality in Brazil: temporal trends and predictions for the year 2030. Medicine. 2015; 94(16):e746. https://doi.org/10.1097/md.0000000000000746.
Drouillard A, Manfredi S, Lepage C, Bouvier AM. Épidémiologie Du Cancer Du Pancréas. Bull Cancer. 2018; 105(1):63-9. https://doi.org/10.1016/j.bulcan.2017.11.004.
Usón Junior PLS, França MS, Rodrigues HV, Macedo AL de V, Goldenberg A, Smaletz O, et al. Higher overall survival in metastatic pancreatic cancer: the impact of where and how treatment is delivered. Einstein (São Paulo). 2015; 13(3):347-51. https://dx.doi.org/10.1590%2FS1679-45082015AO3303.
Maisonneuve P, Lowenfels AB. Risk factors for pancreatic cancer: A summary review of meta-analytical studies. Int J Epidemiol. 2015; 44(1):186-98. https://doi.org/10.1093/ije/dyu240.
Capurso G. Methods and outcomes of screening for pancreatic adeno-carcinoma in high-risk individuals. World J Gastrointest Endosc. 2015; 7(9):833. https://doi.org/10.1093/ije/dyu240.
Ohl ICB, Ohl RIB, Chavaglia SRR, Goldman RE. Public actions for control of breast cancer in Brazil: integrative review. Rev Bras Enferm. 2016; 69(4):746-55. http://dx.doi.org/10.1590/0034-7167.2016690424i.
Barbosa IR, Costa ICC, Pérez, MMB, Souza, DLB. Desigualdades socioeconômicas e mortalidade por câncer: um estudo ecológico no Brasil. Rev Bras Promoç Saúde. 2016; 29(3):350-6. https://doi.org/10.5020/18061230.2016.p350.
Ferlay J, Colombet M, Bray F. Incidência de Câncer nos Cinco Continentes, CI5 mais: IARC. Cancer Base No. 9. Lyon, França: Agência Internacional de Pesquisa sobre Câncer; 2018.
World Health Organization (WHO) Databank. Health statistics and information systems, Geneva, Switzerland: WHO.
Program JR. Version 4.5.0.0. Statistical methodology and applications branch, Surveillance Research Program, National Cancer Institute.
Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000; 19:335-51. https://doi.org/10.1002/(sici)1097-0258(20000215)19:3%-3C335::aid-sim336%3E3.0.co;2-z.
Barbosa IR, dos Santos CA, de Souza DLB. Pancreatic cancer in Brazil: Mortality trends and projections until 2029. Arq Gastroenterol. 2018; 55(3):230-6. https://doi.org/10.1590/S0004-2803.201800000-59.
Lin QJ, Yang F, Jin C, Fu DL. Current status and progress of pancreatic cancer in China. World J Gastroenterol. 2015; 21(26):7988-8003. https://doi.org/10.3748/wjg.v21.i26.7988.
Carrato A, Falcone A, Ducreux M, Valle JW, Parnaby A, Djazouli K, et al. A Systematic Review of the Burden of Pancreatic Cancer in Europe: Real-World Impact on Survival, Quality of Life and Costs. J Gastrointest Cancer. 2015; 46(3):201-11. https://doi.org/10.1007/s12029-015-9724-1.
Simard EP, Ward EM, Siegel R, Jemal A. Cancers with increasing incidence trends in the United States: 1999 through 2008. CA Cancer J Clin. 2012; 62(2):118-28. https://doi.org/10.1007/s12029-015-9724-1.
Soldan M. Rastreamento de Câncer de Pâncreas. Rev Col Bras Cir. 2017; 44(2):109-11. https://doi.org/10.1590/0100-69912017002015.
Pourhoseingholi MA, Ashtari S, Hajizadeh N, Fazeli Z, Zali MR. Systematic review of pancreatic cancer epidemiology in Asia-Pacific Region: major patterns in GLOBACON 2012. Gastroenterol Hepatol Bed Bench. 2017; 10(4):245-257. DOI: https://doi.org/10.1016/j.ebiom.2016.12.015
Valencia-Vargas A, Hoyos-Duque SI, Vásquez-Trespalacios EM. Factores asociados con la supervivencia al año de pacientes operados con cáncer ampular o de páncreas. Rev. salud pública. 2016; 18(6): 913-25. http://dx.doi.org/10.15446/rsap.v18n6.42435.
Gupta S, Gupta R, Sinha DN, Mehrotra R. Relationship between type of smokeless tobacco & risk of cancer: A systematic review. Indian J Med Res. 2018; 148(1):56-76. https://doi.org/10.4103/ijmr.ijmr_2023_17.
Lugo A, Peveri G, Bosetti C, Bagnardi V, Crippa A, et al. Strong excess risk of pancreatic cancer for low frequency and duration of cigarette smoking: A comprehensive review and meta-analysis. Eur J Cancer. 2018; 104:117-26. https://doi.org/10.1016/j.ejca.2018.09.007.
Bang UC, Benfield T, Hyldstrup L, Bendtsen F, Beck Jensen JE. Mortality, cancer, and comorbidities associated with chronic pancreatitis: A Danish nationwide matched-cohort study. gastroenterology. 2014; 146(4):989-94. https://doi.org/10.1053/j.gastro.2013.12.033.
Cazacu IM, Farkas N, Garami A, Balaskó M, Mosdósi B, et al. Pancreatitis-associated genes and pancreatic cancer risk: a systematic review and meta-analysis. Pancreas. 2018; 47(9):1078. https://doi.org/10.1097/mpa.0000000000001145.
Er KC, Hsu CY, Lee YK, Huang MY, Su YC. Effect of glycemic control on the risk of pancreatic cancer A nationwide cohort study. Medicine (Baltimore). 2016; 95(24). https://doi.org/10.1097/MD.0000000000003921.
Rajeshkumar NV, Dutta P, Yabuuchi S, de Wilde RF, Martinez GV, Le A, Kamphorst JJ, Rabinowitz JD, Jain SK, Hidalgo M, et al. Therapeutic targeting of the Warburg effect in pancreatic cancer relies on an absence of p53 function. Cancer Res. 2015; 75:3355-64. https://doi.org/10.1158/0008-5472.can-15-0108.
Tan J, You Y, Guo F, Xu J, Dai H, et al. Association of elevated risk of pancreatic cancer in diabetic patients: A systematic review and meta-analysis. Oncology letters. 2017; 13(3):1247-55. https://dx.doi.org/10.3892%2Fol.2017.5586.
Guerrero-Núñez S, Valenzuela-Suazo S, Cid-Henríquez P. Cobertura Universal Efetiva da Diabetes Mellitus tipo 2 em Chile. Rev Latino-Am Enfermagem. 2017; 25:e2871. DOI: https://doi.org/10.1590/1518-8345.1630.2871
Sartorelli DS, Franco LJ. Tendências do diabetes mellitus no Brasil: o papel da transição nutricional. Cad Saúde Pública. 2003; 19:S29-S36. https://doi.org/10.1590/S0102-311X2003000700004.
Iser BPM, Stopa SR, Chueiri PS, Szwarcwald CL, Malta DC, Monteiro HODC, Schmidt MI. Prevalência de diabetes autorreferido no Brasil: resultados da Pesquisa Nacional de Saúde 2013. Epidemiol. Serv. Saúde. 2015; 24:305-14. https://doi.org/10.5123/S1679-49742015000200013.
Borges DDB, Lacerda JTD. Ações voltadas ao controle do Diabetes Mellitus na Atenção Básica: proposta de modelo avaliativo. Saúde debate. 2018; 42(116):162-78. https://doi.org/10.1590/0103-1104201811613.
Gordon-Dseagu VL, Devesa SS, Goggins M, Stolzenberg-Solomon R. Pancreatic cancer incidence trends: Evidence from the Surveillance, Epidemiology and End Results (SEER) population-based data. Int J Epidemiol. 2018; 47(2):427-39. https://doi.org/10.1093/ije/dyx232.
Malvezzi M, Carioli G, Bertuccio P, Negri E, La Vecchia C. Relation between mortality trends of cardiovascular diseases and selected cancers in the European Union, in 1970–2017, Focus on cohort and period effects. Eur J Cancer. 2018; 103:341-55. https://doi.org/10.1016/j.ejca.2018.06.018.
Flook R, van Zanten SV. Pancreatic cancer in Canada: incidence and mortality trends from 1992 to 2005. Can J Gastroenterol. 2009; 23(8):546-50. https://doi.org/10.1155/2009/986531.
Wong MC, Jiang JY, Liang M, Fang Y, Yeung MS, Sung JJ. Global temporal patterns of pancreatic cancer and association with socioeconomic development. Scientific reports. 2017; 7:3165. https://doi.org/10.1038/s41598-017-02997-2.
Cómo citar
APA
ACM
ACS
ABNT
Chicago
Harvard
IEEE
MLA
Turabian
Vancouver
Descargar cita
Licencia
Derechos de autor 2022 Revista de Salud Pública
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
Esta revista provee acceso libre inmediato a su contenido bajo el principio de que hacer disponible gratuitamente investigación al publico apoya a un mayor intercambio de conocimiento global.
Todos los contenidos de esta revista, excepto dónde está identificado, están publicados bajo una Licencia Creative Commons Atribución 4.0.
